As renal inflammation contributes to the development of diabetic nephropathy (Wada and Makino 2013), we further investigated whether the renoprotective effect of adiponectin as described above is associated with a reduction in renal inflammation. Here, ADIPOQ is linked to diabetic kidney disease.